Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Commonwealth Biotechnologies CBTE - Genomics/DNA Seq -- Ignore unavailable to you. Want to Upgrade?

To: lloyd bashaw who wrote (1)	2/17/2000 9:14:00 AM
From: songw	Read Replies (2) \| Respond to of 16

CBTE - PE Biosystems Lic. Deal - SEC Filings '99 According to SEC filings from last year CBTE has licensing deal for "protein nucleic acids" with a division of PE Biosystems- CRA's sister company. Neither company appears to have ever issued a release. Reading thru CBTE's March 31, 1999 SEC filing gives a great picture of how many different areas of genomic/dna/protein sequencing the company is involved in. But there's one detail buried in the filing that may be of particular interest - "EXPANDED DNA SYNTHESIS SERVICES. The Company provides "protein nucleic acids" (PNAs) to numerous clients under a broad licensing agreement with Perseptive Biosystems, Inc., Framingham, MA. In addition, demand for DNA/RNA synthesis continues to increase, and in particular, the Company is one of the few offering commercial RNA synthesis." tenkwizard.com Perseptive Biosystems is a division of PE Biosystems PEB biz.yahoo.com Last year PE Corp offered two stocks each representing part of its businesses - 1.PE Biosystems PEB-which makes and markets a new and faster machine for genomic sequencing- 2.Celera Genomic CRA- which is mapping the human genome (using its sister company PE Biosystems machines) Both PEB and CRA have rocketed in recent months in excitment over the prospects for the genomic sciences. pecorporation.com pecorporation.com The filing doesn't go into the nature of the licensing deal between CBTE and PE Biosystems/PerSeptive but some may find it compelling that (according to the filing) the company has some ties with the leaders in the field.